HYP-2A

N/A

Report date: 2025/12/19 10:20:05
NME

Base Information

Drug NameHYP-2A
Drug Alias NameHYP-2AHY-0002HYP-2-A
ClassificationSmall molecules
Mechanisms of ActionKRAS G12C inhibitorsPhosphatidylinositol 3-kinase inhibitors
TargetsKRAS G12CPhosphatidylinositol 3-kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan Huiyu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Huiyu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A